Recognizing the importance of cancer research and the contributions of scientists, clinicians, cancer survivors and other patient advocates across the United States who are dedicated to finding a cure for cancer, and supporting the designation of May 2016 as "National Cancer Research Month".

Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; HR 1190 Protecting Seniors Access to Medicare Act of 2015; S. 1177 Every Child Achieves Act; S.1065 School Asthma Management Plan Act; S. 1064 Family Asthma Act; HR 2101 Research for All Act of 2015; S 2956 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; HR 5054 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; S 3040 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; Issues related to the House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; S 3000 Department of Defense Appropriations Act, 2017; HR 5293 Department of Defense Appropriations Act, 2017; S. 3117 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; Issues related to the House Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; S 2837 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; HR 5393 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; HR 2577 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; HR 4974 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; S 2806 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; S. 3068, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5538, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5394 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017; S. 2844 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017 HR 3762 Restoring Americans Healthcare Freedom Reconciliation Act of 2015; HR 3520 Pulmonary Hypertension Research and Diagnosis Act; HR 4662, School-Based Asthma Management Program Act; HR 5263, Women and Lung Cancer Research and Preventive Services Act of 2016; S.2941 - Women and Lung Cancer Research and Preventive Services Act of 2016; H. Res. 717 National Cancer Research Month; S. Res. 459, National Cancer Research Month; Issues related to Medicare and Medicaid reform; Issues related to Moonshot Initiative; Issues related to the Affordable Care Act; Issues related to Asthma, COPD, Influenza, Lung Cancer, Pneumonia, Tuberculosis and other lung diseases; Issues related to the President's Budget; Issues related to the Budget Control Act;

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

FY 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, survivoship, research and programs in FY 2017. National Cancer Moonshot Initiative, meetings and correspondence to discuss services and research for cancer survivors. Endorsement of H.Res. 717/S. Re. 459, supporting cancer research. Comment submitted to the FDA on the draft project proposal for the expanded access navigator for individual patient access. Comment submitted to the FDA in support of the creation of an Oncology Center of Excellence.

Client expense: $60,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE, White House Office